Thanks @Kryptonite
Good to see Acadia progress ROW opportunities ... aiming for Canada by end 2024
I think this slide is also important:
Note NNZ-2591 is back in their slide pack as ACP-2591 for Rett Syndrome and Fragile X .... pink bar above
Footnote: "3 The safety and efficacy of these investigational agents have not been established. There is no guarantee these investigational agents will be filed with or approved by any regulatory agency.
Thanks @KryptoniteGood to see Acadia progress ROW opportunities...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.60 |
Change
0.290(1.50%) |
Mkt cap ! $2.509B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.98 | $19.38 | $5.895M | 299.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 73 | $19.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.62 | 489 | 16 |
View Market Depth
| Last trade - 15.44pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.55 |
Change
0.290 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| $19.41 | $19.97 | $19.39 | 83274 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| NEU (ASX) Chart |